The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Taxol®: The First Microtubule Stabilizing Agent
Open accessAbstract
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent described in the literature. This short review of the mechanism of action of Taxol® emphasizes the research done in the Horwitz’ laboratory. It discusses the contribution of photoaffinity labeled analogues of Taxol® toward our understanding of the binding site of the drug on the microtubule. The importance of hydrogen/deuterium exchange experiments to further our insights into the stabilization of microtubules by Taxol® is addressed. The development of drug resistance, a major problem that arises in the clinic, is discussed. Studies describing differential drug binding to distinct β-tubulin isotypes are presented. Looking forward, it is suggested that the β-tubulin isotype content of a tumor may influence its responses to Taxol®.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Self-citationStructure of the αβ tubulin dimer by electron crystallography
Nogales, E., Wolf, S. G., & Downing, K. H. (1998) · Nature · doi:10.1038/34465 · Cited by 2,076
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Self-citationMicrotubules and resistance to tubulin-binding agents
Kavallaris, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2803 · Cited by 1,120
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Sudakin, V., Chan, G. K. T., & Yen, T. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102093 · Cited by 902
Mechanisms of Taxol resistance related to microtubules
Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727
Self-citationTaxol binds to polymerized tubulin in vitro
Parness, J., & Horwitz, S. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.91.2.479 · Cited by 620
Self-citationKavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., & Horwitz, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119642 · Cited by 601
Self-citationTaxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 553
Phase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
Microtubule Structure at 8 Å Resolution
Li, H., DeRosier, D. J., Nicholson, W. V., Nogales, E., & Downing, K. H. (2002) · Structure · doi:10.1016/s0969-2126(02)00827-4 · Cited by 413
The molecular basis and potential role of survivin in cancer diagnosis and therapy
Altieri, D. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02243-2 · Cited by 412
Mad2-Independent Inhibition of APCCdc20 by the Mitotic Checkpoint Protein BubR1
Tang, Z., Bharadwaj, R., Li, B., & Yu, H. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00019-3 · Cited by 410
Taxol binds to cellular microtubules.
Manfredi, J. J., Parness, J., & Horwitz, S. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.3.688 · Cited by 409
Self-citationMechanisms of Taxol-induced cell death are concentration dependent.
Torres, K. E., & Horwitz, S. B. (1998) · PubMed · Cited by 385
Self-citationRaf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny, M. V., Giannakakou, P., El‐Deiry, W. S., Kingston, D. G. I., Higgs, P. I., Neckers, L. M., & Fojo, T. (1997) · PubMed · Cited by 382
Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J. B., & Neckers, L. (1996) · PubMed · Cited by 375
Schiff, P. B., & Horwitz, S. B. (1981) · Biochemistry · doi:10.1021/bi00514a041 · Cited by 368
Self-citationTubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Zhu, M.-L., Horbinski, C. M., Garzotto, M., Qian, D. Z., Beer, T. M., & Kyprianou, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0585 · Cited by 352
Insights into the mechanism of microtubule stabilization by Taxol
Xiao, H., Verdier-Pinard, P., Fernandez-Fuentes, N., Burd, B., Angeletti, R., Fiser, A., Horwitz, S. B., & Orr, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603704103 · Cited by 319
Self-citationMitosis is not a key target of microtubule agents in patient tumors
Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 314 · cited 2×
“Although Taxol® was primarily thought of as a drug that acts in the mitotic phase of the cell cycle, it has become clear that Taxol® has effects on microtubules throughout the cell cycle; its presence in a cell has a variety of consequences, many of which occur in interphase cells [12,13].”
BackgroundBRCA1 is associated with the centrosome during mitosis
Hsu, L.-C., & White, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12983 · Cited by 310
Kamath, K., Wilson, L., Cabral, F., & Jordan, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414477200 · Cited by 247
3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.
Rao, S., Krauss, N. E., Heerding, J. M., Swindell, C. S., Ringel, I., Orr, G. A., & Horwitz, S. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41836-9 · Cited by 245
Self-citationCharacterization of the Taxol Binding Site on the Microtubule
Rao, S., Orr, G. A., Chaudhary, A. G., Kingston, D. G. I., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20235 · Cited by 235
Self-citationDifferential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen, J.-G., & Horwitz, S. B. (2002) · PubMed · Cited by 212
Self-citationGiannakakou, P., Nakano, M., Nicolaou, K. C., O'Brate, A., Yu, J., Blagosklonny, M. V., Greber, U. F., & Fojo, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132275599 · Cited by 205
Chorny, M., Fishbein, I., Yellen, B. B., Alferiev, I. S., Bakay, M., Ganta, S., Adamo, R., Amiji, M., Friedman, G., & Levy, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909506107 · Cited by 197 · cited 1×
“Taxol® has been used in the preparation of stents for cardiac disease [74,75].”
MethodStructural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
Prota, A. E., Bargsten, K., Northcote, P. T., Marsh, M., Altmann, K., Miller, J. H., Díaz, J. F., & Steinmetz, M. O. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307749 · Cited by 195
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello, L. A., McDaid, H. M., Regl, D. L., Yang, C. P., Meng, D., Pettus, T. R. R., Kaufman, M. D., Arimoto, H., Danishefsky, S. J., Smith, A. B., et al. (2000) · PubMed · Cited by 166
Self-citationCharacterization of the Taxol Binding Site on the Microtubule
Rao, S., He, L., Chakravarty, S., Ojima, I., Orr, G. A., & Horwitz, S. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37990 · Cited by 164
Self-citationMartello, L. A., Verdier‐Pinard, P., Shen, H. J., He, L., Torres, K. E., Orr, G. A., & Horwitz, S. B. (2003) · PubMed · Cited by 158
Self-citationA phosphoglycoprotein associated with taxol resistance in J774.2 cells.
Roy, S. N., & Horwitz, S. B. (1985) · PubMed · Cited by 158
Self-citationDirect Photoaffinity Labeling of Tubulin With Taxol
Rao, S. P. S., Horwitz, S. B., & Ringel, I. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.10.785 · Cited by 154
Self-citationAndrogen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus
Thadani‐Mulero, M., Nanus, D. M., & Giannakakou, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0783 · Cited by 151
A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance
Gonzalez‐Garay, M. L., Chang, L., Cabral, F., Blade, K. L., & Menick, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23875 · Cited by 150
Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen, J.-G., Yang, C.-P. H., Cammer, M., & Horwitz, S. B. (2003) · PubMed · Cited by 132
Self-citationHe, L., Yang, C. P., & Horwitz, S. B. (2001) · PubMed · Cited by 131
Self-citationPaclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Ganguly, A., Yang, H., & Cabral, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0552 · Cited by 130
Ak, B., Roach, M., Trcka, P. P., & Ludueña, R. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42811-6 · Cited by 120
Brunden, K. R., Lee, V. M. ‐., Smith, A. B., Trojanowski, J. Q., & Ballatore, C. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.021 · Cited by 117
Liu, Y., Bhalla, K. N., Hill, C. K., & Prlest, D. G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90164-3 · Cited by 116
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
Prota, A. E., Bargsten, K., Northcote, P. T., Marsh, M., Altmann, K., Miller, J. H., Díaz, J. F., & Steinmetz, M. O. (2014) · Angewandte Chemie · doi:10.1002/ange.201307749 · Cited by 113
The Seco-Taxane IDN5390 Is Able to Target Class III β-Tubulin and to Overcome Paclitaxel Resistance
Ferlini, C., Raspaglio, G., Mozzetti, S., Cicchillitti, L., Filippetti, F., Gallo, D., Fattorusso, C., Campiani, G., & Scambia, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3065 · Cited by 107
Class III β-tubulin in normal and cancer tissues
Mariani, M., Karki, R., Spennato, M., Pandya, D. S., He, S., Andreoli, M., Fiedler, P. N., & Ferlini, C. (2015) · Gene · doi:10.1016/j.gene.2015.03.061 · Cited by 104
Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi.
Baum, S. G., Wittner, M., Nadler, J. P., Horwitz, S. B., Dennis, J. E., Schiff, P. B., & Tanowitz, H. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4571 · Cited by 101
Self-citationHallmarks of Molecular Action of Microtubule Stabilizing Agents
Baine, M. K., Menon, V., Yang, C. H., Northcote, P. T., Miller, J. H., Angeletti, R. H., Fiser, A., Horwitz, S. B., & Xiao, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162214 · Cited by 78
Self-citationPotentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice
Huang, G. S., Lopez-Barcons, L. A., Freeze, B. S., Smith, A. B., Goldberg, G. L., Horwitz, S. B., & McDaid, H. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0229 · Cited by 76
Self-citationMasurovsky, E. B., Peterson, E. R., Crain, S. M., & Horwitz, S. B. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90148-3 · Cited by 75
Self-citationMurphy, D. B., & Wallis, K. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82073-0 · Cited by 72
Runowicz, C. D., Wiernik, P. H., Einzig, A. I., Goldberg, G. L., & Horwitz, S. B. (1993) · Cancer · doi:10.1002/cncr.2820710442 · Cited by 72
Self-citationIkui, A. E., Yang, C. H., Matsumoto, T., & Horwitz, S. B. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2061 · Cited by 69
Self-citationSubcellular localization of the BRCA1 gene product in mitotic cells
Lotti, L. V., Ottini, L., D’Amico, C., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10105 · Cited by 64
A highly epothilone B–resistant A549 cell line with mutations in tubulin that confer drug dependence
Yang, C. H., Verdier‐Pinard, P., Wang, F., Lippaine-Horvath, E., He, L., Li, D., Höfle, G., Ojima, I., Orr, G. A., & Horwitz, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0024 · Cited by 63
Self-citationTaxol mediates serine phosphorylation of the 66-kDa Shc isoform.
Yang, C. H., & Horwitz, S. B. (2000) · PubMed · Cited by 52
Self-citationBaine, M. K., Menon, V., Verdier‐Pinard, P., Smith, A. B., Angeletti, R. H., Fiser, A., Horwitz, S. B., & Xiao, H. (2009) · Biochemistry · doi:10.1021/bi901351q · Cited by 52
Self-citationNew insights into mechanisms of resistance to microtubule inhibitors
Ganguly, A., & Cabral, F. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.06.001 · Cited by 50
RÜDIGER, M., & Weber, K. K. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18357.x · Cited by 50
Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells
Ganguly, A., Yang, H., Zhang, H., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0401 · Cited by 40
Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration
Ganguly, A., Yang, H., & Cabral, F. (2011) · Oncotarget · doi:10.18632/oncotarget.250 · Cited by 39
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
Matesanz, R., Trigili, C., Rodríguez‐Salarichs, J., Zanardi, I., Pera, B., Nogales, A., Fang, W., Jiménez‐Barbero, J., Canales, Á., Barasoaı́n, I., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.048 · Cited by 36
Wiesen, K. M., Xia, S., Yang, C. H., & Horwitz, S. B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.022 · Cited by 36
Self-citation2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes
Yang, C., Yap, E.-H., Xiao, H., Fiser, A., & Horwitz, S. (2016) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1613286113 · Cited by 28
Self-citationLee, C., Yu, C., Chang, S., Hung, K., Liu, S., Wang, C., Hsu, M., Hsieh, C., Chen, W.-J., Ko, Y.-S., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67721 · Cited by 26
Proteomics of Cancer Cell Lines Resistant to Microtubule-Stabilizing Agents
Albrethsen, J., Angeletti, R. H., Horwitz, S. B., & Yang, C. H. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0471 · Cited by 25
Self-citation
Cited by
Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
Steinmetz, M. O., & Prota, A. E. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.001 · Cited by 461
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Therapeutic strategies to overcome taxane resistance in cancer
Das, T., Anand, U., Pandey, S. K., Ashby, C. R., Assaraf, Y. G., Chen, Z.-S., & Dey, A. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100754 · Cited by 253
Zhai, J., Gu, X., Liu, Y., Hu, Y., Jiang, Y., & Zhang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152934 · Cited by 131
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
Metadata
- Authors
- Yang, C.-P., & Horwitz, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-09
- Volume
- 18
- Issue
- 8
- Pages
- 1733
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2744422984
- Cited by
- 284
- References
- 68
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.